TY - JOUR
T1 - Inhibition of ischemic brain edema formation by post-ischemic administration of a prostaglandin oligomer
AU - Ohnishi, S. Tsuyoshi
AU - Tominaga, T.
AU - Katsuoka, M.
N1 - Funding Information:
The authors would like to thank Mr. Mark Singer, BioMediCon for his assistance in preparing the manuscript. This study was supported by a research grant from RHD, Inc.. Tokyo. Japan.
PY - 1989/8
Y1 - 1989/8
N2 - We studied the efficacy of an oligomeric derivative of prostaglandin E1 in protecting the rat brain against focal ischemia. The degree of ischemic damage was evaluated from three parameters, namely, the degree of edema formation, reduction of motor performance, and memory disturbance as measured by a passive avoidance test. The pre-ischemic administration of the drug (6 mg/kg i.p.) had some effects, but the differences were not significant. The post-ischemic administration (6 mg/kg i.p.) produced significant improvement in all three parameters. The increase of water content of the ischemic hemisphere was reduced (p<0.05); the total motor score was improved (p<0.01); and the memory disturbance as estimated by the passive avoidance test was reduced (p<0.01). A possible mechanism of protection is discussed.
AB - We studied the efficacy of an oligomeric derivative of prostaglandin E1 in protecting the rat brain against focal ischemia. The degree of ischemic damage was evaluated from three parameters, namely, the degree of edema formation, reduction of motor performance, and memory disturbance as measured by a passive avoidance test. The pre-ischemic administration of the drug (6 mg/kg i.p.) had some effects, but the differences were not significant. The post-ischemic administration (6 mg/kg i.p.) produced significant improvement in all three parameters. The increase of water content of the ischemic hemisphere was reduced (p<0.05); the total motor score was improved (p<0.01); and the memory disturbance as estimated by the passive avoidance test was reduced (p<0.01). A possible mechanism of protection is discussed.
UR - http://www.scopus.com/inward/record.url?scp=0024411333&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024411333&partnerID=8YFLogxK
U2 - 10.1016/0952-3278(89)90106-3
DO - 10.1016/0952-3278(89)90106-3
M3 - Article
C2 - 2780765
AN - SCOPUS:0024411333
SN - 0952-3278
VL - 37
SP - 107
EP - 111
JO - Prostaglandins Leukotrienes and Essential Fatty Acids
JF - Prostaglandins Leukotrienes and Essential Fatty Acids
IS - 2
ER -